Quick Order Cart

Cat. No. ARG34664

KIFAP3 Knockout HAP1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone Marrow

  • Disease:

    Chronic myeloid leukemia

The KIFAP3 Knockout HAP1 Polyclonal Cells consist of a CRISPR/Cas9-edited polyclonal KIFAP3 knockout population in HAP1 cells, a near-haploid human cell line widely used for genetic perturbation studies. KIFAP3 encodes a critical non-motor subunit of the kinesin-2 motor complex that drives anterograde intraflagellar transport and is essential for ciliogenesis. Loss of KIFAP3 disrupts ciliary assembly and attenuates hedgehog signaling by impairing the trafficking of IFT particles and reducing GLI2-mediated transcription. This knockout model supports applications in ciliopathy research, hedgehog pathway analysis, and intracellular transport studies, offering a reliable tool for functional genomics and drug discovery.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HAP1

    Sex of Donor

    Male

    Age

    40 years

    Derived From Site

    Bone marrow

    Gene Name

    KIFAP3

    Gene Identifier

    NCBI Gene ID 22920

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    IMDM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The KIFAP3 Knockout HAP1 Polyclonal Cells product provides a CRISPR/Cas9-edited polyclonal knockout cell population targeting the KIFAP3 gene in HAP1 cells. This gene-edited pool is designed for functional studies requiring loss of KIFAP3 expression without clonal isolation, enabling robust analysis of gene function in a controlled genetic background. The polyclonal nature of the knockout population ensures genetic diversity while maintaining consistent disruption of the target locus, making it suitable for high-throughput screening and pathway interrogation in cell-based assays.

HAP1 is a near-haploid human cell line derived from the KBM-7 chronic myeloid leukemia isolate. Its haploid karyotype simplifies gene knockout studies, as a single targeting event is sufficient to disrupt gene function, facilitating the generation of homozygous-like null phenotypes. HAP1 cells retain the capacity to form primary cilia, express key components of the hedgehog signaling machinery, and are amenable to a wide range of molecular and imaging assays, positioning them as a versatile model system for studying ciliary biology and signal transduction.

KIFAP3 encodes a non-motor subunit of the heterotrimeric kinesin-2 motor complex, which is essential for anterograde intraflagellar transport (IFT) along ciliary microtubules. KIFAP3 forms a functional complex with motor subunits KIF3A and KIF3B and interacts with IFT particles including IFT20 and IFT88 to mediate cargo delivery required for ciliogenesis. Its activity is modulated by phosphorylation via upstream kinases CDK5 and GSK3??. Disruption of KIFAP3 abolishes proper IFT, leading to defective ciliary assembly and attenuated hedgehog signaling. This is evidenced by impaired translocation of smoothened (SMO) and reduced transcriptional activity of GLI2, a downstream effector, ultimately compromising the expression of hedgehog target genes such as GLI1.

In the HAP1 cellular context, KIFAP3 knockout disrupts the formation and maintenance of primary cilia, providing a powerful model to dissect the molecular requirements of IFT-dependent ciliogenesis. Because HAP1 cells rely on functional kinesin-2 for hedgehog signal transduction, loss of KIFAP3 results in blockade of the pathway, mimicking aspects of ciliopathy phenotypes. This isogenic system allows direct comparison between wild-type and KIFAP3-deficient cells, enabling quantitative assessment of ciliary length, trafficking dynamics, and signal responsiveness without confounding genetic variability. The model is therefore particularly relevant for investigating mechanisms underlying retinitis pigmentosa and other ciliopathies where kinesin-2 dysfunction is implicated.

Typical applications include ciliopathy modeling, hedgehog pathway dissection, intracellular transport studies, and validation of CRISPR screening hits. Researchers can employ western blotting to confirm KIFAP3 protein depletion, immunofluorescence to visualize ciliary markers such as IFT88 and ARL13B, RT-qPCR to measure GLI1 and GLI2 transcript levels, and cilia formation assays to quantify ciliogenesis defects. Flow cytometry-based ciliary signaling assays and hedgehog luciferase reporter systems further extend the utility of this model in drug discovery and functional genomics. For further technical details or to place an order, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)